Dr Pepper Falls Short Of Revenue Estimates But Raises EPS Guidance
Dr Pepper Snapple (NYSE:DPS) beat the consensus EPS estimate but fell short of revenue estimates in the first quarter, as the recent acquisition of Bai Brands boosted results for the company. In Q1, sales volume rose 1%, including a 0.2% contribution of the incremental Bai sales to third party distributors. Net sales increased 2%, including a 1 percentage point positive impact of the acquisition of Bai, which had sales of $35 million in Q1. Bai was previously an allied brand for Dr Pepper. Allied brands allow Dr Pepper to leverage its large scale distribution network and participate in growing emerging categories where it doesn’t have a considerable presence as of now. The allied brands growth is included in the packaged beverage volumes for Dr Pepper, which is the distribution wing for these small but fast growing brands, such as Vita Coco, etc. Dr Pepper is expected to witness over 1% organic volume growth this year, while the total volume growth is expected to be approximately 2%, inclusive of the Bai acquisition, which closed by the end of January this year.
At the end of last year, Dr Pepper expected 2017 Core EPS in the $4.44 to $4.54 range, but has now increased the range to $4.56 to $4.66, especially due to its high exposure to the domestic market and less exposure to the foreign markets, where negative currency translations could hurt results. Foreign currency translation and transaction were expected to reduce Core EPS by $0.11, primarily driven by the Mexican peso, but are now expected to reduce Core EPS by only $0.07.
- Beating S&P500 BY 11% YTD, What To Expect From Travelers Stock?
- Up 50% Over The Last 12 Months, Is Hyatt Stock Still Attractive?
- Capital One Stock Gained 44% In The Last 6 Months, What’s Next?
- Up 8% Year To Date As 5G Gains Traction, What’s Next For Verizon Stock?
- Up 32% In The Last 12 Months, Where Is BNY Mellon Stock Headed?
- Rallying 30% YTD, What’s Spurring The Rally In Applied Materials’ Stock?
Have more questions on Dr Pepper Snapple? See the links below.
- Earnings Review: Dr Pepper Snapple
- By How Much Does Dr Pepper’s Value Rise If Its Margin Grows By More Than Expected?
- How Can Dr Pepper’s Latin America Segment Grow In The Next Five Years?
- Dr Pepper Snapple Is Heavily Dependent On CSDs, But That’s Not A Problem
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)